BioMarin Pharmaceutical Inc.’s Post

View organization page for BioMarin Pharmaceutical Inc., graphic

169,883 followers

7mo

Our President and CEO Alexander Hardy spoke today at the J.P. Morgan Healthcare Conference in San Francisco, sharing his enthusiasm for the company’s mission of improving care for patients and his excitement about BioMarin’s future. In his presentation at the conference, Alexander noted that the company’s proven R&D engine and strong growth potential influenced his decision to join BioMarin late last year. #JPM #JPM24

2 Comments

A3Access Advisors, LLC

7mo

Best of Luck Alexander your leadership, vision and passion are the perfect match for the company’s mission.

Tais Richardson

Capgemini Lifescience, Business Development

7mo

Congratulations for taking the stage and sharing how BioMarin Pharmaceutical Inc. is paving the way with a strong R&D team, amazing focus and mission!

See more comments

To view or add a comment, sign in

More Relevant Posts

Charlie Hunt

Director at Langland (Clinical Trial Experience)| Helping client partners to think further to improve the clinical trial experience
3mo Edited
Report this post
A couple of days on from Patients as Partners and what has really stuck with me are three key takeaways: The importance of measuring the impact of patient engagement, we have to prove this stuff works (there are still naysayers), if we are to truly implement long term change in the industry. Zack Pemberton-Whiteley spoke about this in the Impact measurement framework that Novartis have implemented. Bringing the patient in early on is critical, only then can we design studies that have meaningful patient led endpoints. Lea-Isabelle Proulx summarised this nicely, we have to be patient-centric not science-centric in how we design our protocols. We need to start treating designing the patient experience as a hard science, on a par with the molecule design. DE&I continues to be a hugely important topic, and one that should be at the forefront of every initiative. The panel led by Dr Heidi Green , discussing the 4 myths around DE&I was superb, and great to hear from Robina Weermeijer on what companies like Boehringer are doing here. Thanks to all the amazing speakers and patient advocates that made another great event. April Campbell (née. Veasey) Victoria Wright Sarah McKeown-Cannon #PatientEngagement #ClinicalTrials #PatientsEU2024
3 Comments
Like Comment
To view or add a comment, sign in
Rebecca Steele

Life Sciences Manager @ Vintura | Secretariat for the European Alliance for Value in Health | Strategy and Health Policy
3mo
Report this post
Catch me at the MedTech Europe Forum next week, to talk about our latest report!

Casper Paardekooper

Partner @ Vintura | Trusted advisor | Life Sciences | Strategy, Value in Health, Market & Patient Access, Health Policy, Digital Health
3mo

💬 A Compass for Collaboration: Navigating Stakeholders’ Roles in Transitioning To Value-Based Healthcare Are you attending the MedTech Forum 2024? Please join us for a great session on #VBHC on Thursday 23rd May, 12:00 - 12:50! Together with Stephanie Fridd (Philips), Ilaria Giannico (European Union of Private Hospitals (UEHP)) and Rebecca Steele (Vintura, European Alliance for Value in Health) we will deep dive on the contribution different stakeholders can make in the much needed transition to Value-Based Healthcare #MTF2024 #ValueBasedHealthcare #ValueBasedProcurement #ValueBasedSupply
Like Comment
To view or add a comment, sign in
Jessi Driscoll

Business Development Rep @ TriNetX | Sales, Communication Skills
1mo
Report this post
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/Qrwv30sFjSv #ClinicalTrials #HealthcareInnovation #PatientOutcomes
Like Comment
To view or add a comment, sign in
Vial

12,022 followers
4mo
Report this post
Great insights from David Berry on revolutionizing clinical trials as efforts to efficiently match drugs with patients through improved study design and streamlined execution are paving the way for impactful healthcare innovations. Full episode here: https://lnkd.in/g-vzgsEi
Like Comment
To view or add a comment, sign in
Steven Kundrot
1mo
Report this post
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/VlIP30sEUVN #ClinicalTrials #HealthcareInnovation #PatientOutcomes
Like Comment
To view or add a comment, sign in
Jacob Malaluan

Director, Strategic Sales at TriNetX, MBA Candidate
1mo
Report this post
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/pRBK30sERxh #ClinicalTrials #HealthcareInnovation #PatientOutcomes
Like Comment
To view or add a comment, sign in
Akiko Shimamura

SVP, Trial Design and Optimization at TriNetX | Ex-McKinsey | Healthcare Exec
1mo
Report this post
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/39wP30sEQ1n #ClinicalTrials #HealthcareInnovation #PatientOutcomes
Like Comment
To view or add a comment, sign in
Brecht Claerhout

Chief Health Network Officer at TriNetX, Inc.
2mo
Report this post
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/NuqA30sEAbB #ClinicalTrials #HealthcareInnovation #PatientOutcomes

1 Comment
Like Comment
To view or add a comment, sign in
Helen Reddick

Head of Marketing at Wilmington Healthcare
6mo
Report this post
If you're in MedTech and planning your product launch strategy for the NHS, we've got the perfect webinar for you! Register for free below and don't miss out on this opportunity to gain valuable insights for a successful launch. #MedTech #NHS #productlaunch #webinar

HSJ Information Ltd.

4,039 followers
6mo

There's still time to register for our webinar on Launch Excellence for #MedTech at 14:00 today in association with Med-Tech Innovation. Our experts Jonathan C. and Sarah Denham will be exploring the range of customer needs, market conditions and engagement processes MedTech companies should consider prior to launching a product to the NHS. Register now for this complimentary webinar to gain valuable insights into optimal launch strategies at: https://lnkd.in/eUgmGzyM #launchexcellence #medtech #Wilmhealth

Med-Tech Innovation News | Home

med-technews.com
Like Comment
To view or add a comment, sign in
Jessi Driscoll

Business Development Rep @ TriNetX | Sales, Communication Skills
2mo
Report this post
At TriNetX, we are motivated by the potential for improving patients' lives. Our healthcare organizations have made huge strides in research and securing more sponsored trials, in order to achieve better patient outcomes. Learn more about what drives us: https://ow.ly/fNNr30sE69E #HealthcareInnovation #RealWorldData
Like Comment
To view or add a comment, sign in

169,883 followers

View Profile Follow

BioMarin Pharmaceutical Inc.’s Post

More Relevant Posts

Explore topics